These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17138463)

  • 1. Judgment processes in older adults' drug benefit evaluations.
    Cline RR; Gupta K
    Res Social Adm Pharm; 2005 Mar; 1(1):5-20. PubMed ID: 17138463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug benefit decisions among older adults: a policy-capturing analysis.
    Cline RR; Gupta K
    Med Decis Making; 2006; 26(3):273-81. PubMed ID: 16751326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
    Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
    Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older adults' drug benefit beliefs: construct definition and measure development.
    Cline RR; Gupta K; Singh RL
    Res Social Adm Pharm; 2008 Mar; 4(1):23-36. PubMed ID: 18342820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
    Tjia J; Schwartz JS
    J Am Geriatr Soc; 2006 Apr; 54(4):606-12. PubMed ID: 16686870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of attributes of drug benefit plans: Thai civil servants' perspective.
    Ngorsuraches S; Wanishayakorn T; Tanvejsilp P; Udomaksorn S
    Res Social Adm Pharm; 2013; 9(6):731-40. PubMed ID: 23089296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services.
    Wellman GS; Vidican C
    Res Social Adm Pharm; 2008 Sep; 4(3):218-30. PubMed ID: 18794033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between older adults' knowledge of their drug coverage and medication cost problems.
    Piette JD; Heisler M
    J Am Geriatr Soc; 2006 Jan; 54(1):91-6. PubMed ID: 16420203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index.
    Mullins CD; Palumbo FB; Saba M
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):377-84. PubMed ID: 17567239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary disenrollment from Medicare advantage plans: valuable signals of market performance.
    Mobley LR; McCormack LA; Wang J; Squire C; Kenyon A; Lynch JT; Heller A
    Am J Manag Care; 2007 Dec; 13(12):677-84. PubMed ID: 18069911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE; Cox ER
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promise and perils for patients and physicians.
    Kravitz RL; Chang S
    N Engl J Med; 2005 Dec; 353(26):2735-9. PubMed ID: 16382057
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely?
    Jackson EA; Axelsen KJ
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP29-35. PubMed ID: 18991478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.